Focal epilepsy: genes and variants
Explore variant evidence for Focal epilepsy across 9 analyzed proteins (MECP2, CACNA1A, SCN2A, SCN10A, SCN1A and 4 more). Linked ClinVar records include 4 pathogenic or likely pathogenic variants, 2 variants of uncertain significance and 2 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-10-21. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Focal epilepsy
MECP2: Methyl-CpG-binding protein 2
It interprets DNA methylation and organizes transcriptional and chromatin states that are especially important in mature neurons. Loss-of-function variants cause Rett syndrome, whereas increased dosage causes MECP2 duplication syndrome.
2 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in MECP2 have source records linked to Focal epilepsy. Association strength is not clinical gene validity.
CACNA1A: Voltage-dependent P/Q-type calcium channel subunit alpha-1A
Its P/Q-type calcium current is a major trigger for neurotransmitter release at central synapses and is especially important in cerebellar circuits. Pathogenic variants cause a spectrum including familial hemiplegic migraine, episodic ataxia, spinocerebellar ataxia type 6, epilepsy, and developmental disorders.
1 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in CACNA1A have source records linked to Focal epilepsy. Association strength is not clinical gene validity.
SCN2A: Sodium channel protein type 2 subunit alpha
The protein forms Nav1.2, a voltage-gated sodium channel that carries sodium current during neuronal action potentials. By shaping neuronal excitability and signal propagation, it supports brain circuits involved in development, learning, and seizure susceptibility.
1 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in SCN2A have source records linked to Focal epilepsy. Association strength is not clinical gene validity.
SCN10A: Sodium channel protein type 10 subunit alpha
The protein forms Nav1.8, a tetrodotoxin-resistant voltage-gated sodium channel found in excitable membranes. It helps generate sensory-neuron electrical signals and is especially important in mechanisms of neuropathic pain and inherited episodic pain.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in SCN10A have source records linked to Focal epilepsy. Association strength is not clinical gene validity.
SCN1A: Sodium channel protein type 1 subunit alpha
Its sodium current is especially important for reliable firing of inhibitory interneurons and therefore for balancing excitation across neural networks. Loss-of-function variants are the major cause of Dravet syndrome, while other variants cause GEFS+ or familial hemiplegic migraine.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in SCN1A have source records linked to Focal epilepsy. Association strength is not clinical gene validity.
SCN4A: Sodium channel protein type 4 subunit alpha
Its rapid sodium current initiates and propagates skeletal-muscle action potentials. Gain- and loss-of-function variants cause disorders of muscle excitability including sodium-channel myotonia, paramyotonia congenita, periodic paralysis, and some congenital myopathies.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in SCN4A have source records linked to Focal epilepsy. Association strength is not clinical gene validity.
SCN5A: Sodium channel protein type 5 subunit alpha
Its rapid inward sodium current drives the upstroke of the cardiac action potential and enables fast electrical conduction through atrial, ventricular, and conduction-system tissue. Pathogenic variants can cause long-QT syndrome type 3, Brugada syndrome, conduction disease, and overlapping arrhythmia phenotypes.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in SCN5A have source records linked to Focal epilepsy. Association strength is not clinical gene validity.
SCN8A: Sodium channel protein type 8 subunit alpha
The protein forms Nav1.6, a voltage-gated sodium channel that sets the threshold and propagation of neuronal action potentials. It is widely important for neuronal excitability, and SCN8A variants are associated with developmental and epileptic encephalopathies.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in SCN8A have source records linked to Focal epilepsy. Association strength is not clinical gene validity.
SCN9A: Sodium channel protein type 9 subunit alpha
The protein forms Nav1.7, a voltage-gated sodium channel that amplifies electrical signals in peripheral sensory neurons. Changes in Nav1.7 activity can produce either excessive pain or congenital insensitivity to pain, making SCN9A central to pain biology.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in SCN9A have source records linked to Focal epilepsy. Association strength is not clinical gene validity.
Weakly linked (only a few uncertain records): DEPDC5, CDKL5 and GRIN2A.
ClinVar pathogenic and likely pathogenic variants linked to Focal epilepsy
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| MECP2 K82N | 82 | Pathogenic / likely pathogenic (★★) | |
| MECP2 K305N | 305 | Interaction with TBL1XR1 | Pathogenic / likely pathogenic (★★) |
| CACNA1A Y62C | 62 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| SCN2A W191G | 191 | I | Pathogenic / likely pathogenic (★) |
Same protein, different disease
- Rett syndrome also has ClinVar records linked to MECP2 variants; they fall mostly in different places as the Focal epilepsy variants (88 pathogenic / likely pathogenic).
- Severe neonatal-onset encephalopathy with microcephaly also has ClinVar records linked to MECP2 variants; they fall mostly in different places as the Focal epilepsy variants (29 pathogenic / likely pathogenic).
- X-linked intellectual disability - psychosis - macroorchidism also has ClinVar records linked to MECP2 variants; they fall mostly in different places as the Focal epilepsy variants (4 pathogenic / likely pathogenic).
- Episodic ataxia also has ClinVar records linked to CACNA1A variants; they fall mostly in different places as the Focal epilepsy variants (93 pathogenic / likely pathogenic).
- Developmental and epileptic encephalopathy also has ClinVar records linked to CACNA1A variants; they fall mostly in different places as the Focal epilepsy variants (85 pathogenic / likely pathogenic).
- Spinocerebellar ataxia also has ClinVar records linked to CACNA1A variants; they fall mostly in different places as the Focal epilepsy variants (28 pathogenic / likely pathogenic).
- Familial hemiplegic migraine also has ClinVar records linked to CACNA1A variants; they fall mostly in different places as the Focal epilepsy variants (26 pathogenic / likely pathogenic).
- CACNA1A-related complex neurodevelopmental disorder also has ClinVar records linked to CACNA1A variants; they fall mostly in different places as the Focal epilepsy variants (3 pathogenic / likely pathogenic).
- Developmental and epileptic encephalopathy also has ClinVar records linked to SCN2A variants; they fall mostly in different places as the Focal epilepsy variants (204 pathogenic / likely pathogenic).
- Seizures, benign familial also has ClinVar records linked to SCN2A variants; they fall mostly in different places as the Focal epilepsy variants (167 pathogenic / likely pathogenic).
- Complex neurodevelopmental disorder also has ClinVar records linked to SCN2A variants; they fall mostly in different places as the Focal epilepsy variants (22 pathogenic / likely pathogenic).
- Episodic ataxia also has ClinVar records linked to SCN2A variants; they fall mostly in different places as the Focal epilepsy variants (16 pathogenic / likely pathogenic).
- Spasms also has ClinVar records linked to SCN2A variants; they fall mostly in different places as the Focal epilepsy variants (14 pathogenic / likely pathogenic).
Diseases related to Focal epilepsy
- Epilepsy, also linked to CACNA1A, SCN10A, SCN1A, SCN2A and 4 more
- Cardiac arrhythmia, also linked to SCN10A, SCN1A, SCN2A, SCN4A and 3 more
- Migraine, also linked to SCN10A, SCN1A, SCN2A, SCN4A and 3 more
- Amyotrophic lateral sclerosis, also linked to SCN10A, SCN1A, SCN2A, SCN4A and 2 more
- Lennox-Gastaut syndrome, also linked to SCN10A, SCN1A, SCN2A, SCN8A and 1 more
- Developmental and epileptic encephalopathy, also linked to CACNA1A, SCN1A, SCN2A and SCN8A
- Genetic developmental and epileptic encephalopathy, also linked to SCN1A, SCN2A and SCN8A
- Early-infantile DEE, also linked to SCN1A and SCN8A
- Seizures, benign familial, also linked to SCN2A and SCN8A
- Episodic ataxia, also linked to CACNA1A and SCN2A
- Generalized epilepsy with febrile seizures plus, also linked to SCN1A and SCN9A
- Familial hemiplegic migraine, also linked to CACNA1A and SCN1A
Frequently asked questions
Which genes have records linked to Focal epilepsy?
This view contains 9 analyzed proteins: MECP2, CACNA1A, SCN2A, SCN10A, SCN1A and 4 more. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 4 pathogenic or likely pathogenic variants, 2 variants of uncertain significance and 2 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 10 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center